Five Prime Therapeutics, Inc. Restricted Cash
Five Prime Therapeutics, Inc. had Restricted Cash of $1.54 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2021-03-22
- 2020-12-31: Restricted Cash $1.54M.
- 2020-09-30: Restricted Cash $1.54M.
- 2020-06-30: Restricted Cash $1.54M.
- 2020-03-31: Restricted Cash $1.54M.
| Period end | Restricted Cash |
|---|---|
| 2020-12-31 | $1.54M 10-K · filed 2021-03-22 |
| 2020-09-30 | $1.54M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $1.54M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.54M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.54M 10-K · filed 2021-03-22 |
| 2019-09-30 | $1.54M 10-Q · filed 2020-11-03 |
| 2019-06-30 | $1.54M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $1.54M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $1.54M 10-K · filed 2021-03-22 |
| 2018-09-30 | $1.54M 10-Q · filed 2019-11-06 |
| 2018-06-30 | $1.54M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $1.54M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $1.54M 10-K · filed 2021-03-22 |
| 2017-09-30 | $1.54M 10-Q · filed 2018-11-06 |
| 2017-06-30 | $1.54M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $1.54M 10-Q · filed 2018-05-08 |
| 2016-12-31 | $1.54M 10-K · filed 2020-02-27 |